Contributions to the Optimal Use of Human Blood
暂无分享,去创建一个
[1] H. Brummelhuis,et al. Contributions to the Optimal Use of Human Blood , 1976 .
[2] H. Brummelhuis,et al. Contributions to the Optimal Use of Human Blood , 1975, Vox sanguinis.
[3] H. Brummelhuis,et al. Contributions to the Optimal Use of Human Blood , 1973, Vox sanguinis.
[4] Vogelaar Ef,et al. Contributions to the Optimal Use of Human Blood , 1972, Vox sanguinis.
[5] P. Lachmann,et al. Hereditary angio‐oedema: a review with particular reference to pathogenesis and treatment , 1971, Clinical allergy.
[6] N. Heimburger,et al. Ein Beitrag zur Isolierung und Charakterisierung des C‐Inaktivators aus Humanplasma , 1970 .
[7] H. Brummelhuis. Technical Aspects and Results of the Determination of Hepatitis Associated Antigen (HAA) and Antibody , 1970, Vox sanguinis.
[8] H. Gewurz,et al. Replacement therapy in hereditary angioedema. Successful treatment of two patients with fresh frozen plasma. , 1969, Lancet.
[9] J. Pool,et al. Production of high-potency concentrates of antihemophilic globulin in a closed-bag system. , 1965, The New England journal of medicine.
[10] J. Heremans,et al. Immunochemical quantitation of antigens by single radial immunodiffusion. , 1965, Immunochemistry.
[11] C. Hinz,et al. CHROMATOGRAPHIC RESOLUTION OF THE FIRST COMPONENT OF HUMAN COMPLEMENT INTO THREE ACTIVITIES , 1963, The Journal of experimental medicine.
[12] J. Pensky,et al. Partial purification of a serum inhibitor of C'1-esterase. , 1961, The Journal of biological chemistry.
[13] I. Lepow,et al. Assay and Properties of Serum Inhibitor of C'1-Esterase∗ , 1959, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[14] Vogelaar Ef,et al. Studies on the Preparation and Stability of Immunoglobulin Concentrates , 1972 .
[15] D. Schultz,et al. The separation of nine components and two inactivators of components of complement in humansserum. , 1970, Immunochemistry.